Facilities

Phase 1 Capability

Phase 1 population

All of these

Mechanisms studied

Several, including HSP90 inhibitors, PARP inhibitors (list of ASCO/AACR abstracts in 2006/7 available if requested)

First-in-Man studies

Yes

Centre specific translational research interest

Yes, circulating tumour cells

Multi-centre Phase 1 studies

Yes

 

Technology/equipment available within the centre

  • MRI/MRS (including diffusion-weighted MRI)
  • CT/PET
  • automated immunohistochemistry (Ariol™ system)
 

Hospital sites

The Royal Marsden